Director Kirk Thomas F increased his direct ownership in Myomo, Inc. (NYSE: MYO) by purchasing 72,000 common shares on March 13, 2026. The transaction carried a total value of $51,112, with execution prices between $0.70 and $0.71 and a weighted average price of $0.7099. Following this purchase, Kirk directly owns 553,857 shares of the company.
The insider purchase takes place against a challenging market backdrop for the stock. MYO has fallen roughly 86% over the last 12 months and is trading near its 52-week low of $0.63. According to InvestingPro analysis cited by the company, the shares appear undervalued relative to Fair Value metrics, and additional proprietary research on MYO is available through the platform's Pro Research Report covering more than 1,400 U.S. equities.
Operationally, Myomo reported fourth-quarter revenue of $11.4 million, topping the Street estimate of $10.4 million. The company posted an adjusted EBITDA loss of $1.9 million, which was narrower than the consensus expectation of a negative $3.0 million. Those results present a mixed picture: revenue exceeded analyst forecasts while the business remains unprofitable on an adjusted EBITDA basis.
Despite the revenue beat and improved adjusted EBITDA relative to expectations, Craig-Hallum reduced its price target on Myomo to $1.10 from $2.00. The firm cited the combination of mixed quarterly results and fiscal 2026 guidance that fell short of Wall Street projections as the rationale for the lower target.
On the commercial access front, Myomo has executed network participation agreements with Elevance Health. The agreements will extend coverage across Anthem-affiliated Commercial, Medicare Advantage, and Medicaid plans and could add as many as 45 million medical members to the company’s potential coverage by the second quarter of 2026. Including this expansion, Myomo expects to have more than 80 million covered lives under commercial insurance plans.
Management also elected a change in compensation structure for 2026. CEO Paul Gudonis and CFO David Henry have agreed to reduce their base salaries by 10% for 2026 in exchange for restricted stock units. The company’s Compensation Committee approved a program under which the executives will receive RSUs valued at 115% of the salary amounts they forego. The company described these moves as part of efforts to align executive compensation with company performance.
Taken together, the insider purchase, the quarterly results, the expanded insurance network, and the executive compensation changes represent a cluster of developments that stakeholders will monitor for their implications on Myomo’s commercial reach and financial trajectory. The mix of a revenue beat alongside continued adjusted EBITDA losses and a lower analyst price target underscores the uncertain path to sustained profitability.
Sectors affected: Healthcare services and small-cap equity markets.